ATRS - アンタレス・ファ―マ (Antares Pharma Inc.) アンタレス・ファ―マ

 ATRSのチャート


 ATRSの企業情報

symbol ATRS
会社名 Antares Pharma Inc. (アンタレス・ファ―マ)
分野(sector) Health Care   ヘルスケア
産業(industry) Medical/Dental Instruments  
業種 医療機器_医療用品_ディストリビュ―タ―   医療関連(Health Care)
概要 事業概要 アンタレス・ファーマ(Antares Pharma Inc.)は自己投与される非経口医薬品および技術の開発・商業化に従事する専門医薬品会社である。同社は患者が薬物を自己注射することを可能にするニードル有り・無しの圧力補助式注射器を開発・製造する。同社の皮下注射技術プラットフォームは、VIBEX使い捨て圧力支援自動インジェクタ、Vision再使用可能な無針注射器、及び使い捨ての多目的ペンインジェクタを含む。同社は薬物送達事業セグメントを通じて運営する。薬物送達事業は自己投与される非経口医薬品および技術を含む。同社は単回用量の使い捨て自動注射器であるOTREXUP(メトトレキセート)注射剤を開発した。   アンタレス・ファ―マは、米国の医薬品メ―カ―。無針・微小針の注射システムや経皮ジェルなどの薬品送達システムを開発、製造、販売する。主な商品は、関節リウマチに対するメトトレキサ―トの皮下注製剤「OTREXUP」、自己注製剤「Medi-Jet」、使い捨て可能な自動注入器「Vibex」など。本社は、ニュ―ジャ―ジ―州イウィング。   Antares Pharma, Inc. is a pharmaceutical technology company focused primarily on the development and commercialization of self-administered injectable pharmaceutical products using advanced drug delivery auto injector technology. The Company has a portfolio of proprietary and partnered commercial products with several product candidates in various stages of development, as well as significant strategic alliances with industry leading pharmaceutical companies including Teva Pharmaceutical Industries, Ltd. (Teva), Covis Pharma (Covis), Pfizer Inc. (Pfizer) and Idorsia Pharmaceuticals Ltd. (Idorsia). Antares Pharma's FDA-approved products include XYOSTED® (testosterone enanthate) injection, OTREXUP® (methotrexate) injection for subcutaneous use and Sumatriptan Injection USP, which is distributed by Teva. The Company also markets NOCDURNA® (desmopressin acetate) in the U.S., which was licensed from Ferring Pharmaceuticals.
本社所在地 100 Princeton South Suite 300 Ewing NJ 08628 USA
代表者氏名 Leonard S. Jacob レオナルドS.ジェイコブ
代表者役職名 Independent Chairman of the Board
電話番号 +1 609-359-3020
設立年月日 1979年
市場名 NASDAQ Small Cap
ipoyear ―年
従業員数 111人
url www.antarespharma.com
nasdaq_url https://www.nasdaq.com/symbol/atrs
adr_tso
EBITDA EBITDA(百万ドル) -16.15604
終値(lastsale) 3.75
時価総額(marketcap) 590387628.75
時価総額 時価総額(百万ドル) 573.06960
売上高 売上高(百万ドル) 55.95639
企業価値(EV) 企業価値(EV)(百万ドル) 569.27960
当期純利益 当期純利益(百万ドル) -19.88014
決算概要 決算概要 BRIEF: For the six months ended 30 June 2018 Antares Pharma Inc revenues increased 6% to $26.9M. Net loss increased 41% to $10.7M. Revenues reflect Europe segment increase of 42% to $3.2M United States of America segment increase of 3% to $23.4M. Higher net loss reflects Research and development increase of 12% to $7M (expense) Selling general and administrative increase of 3% to $15.3M (expense).

 ATRSのテクニカル分析


 ATRSのニュース

   Antares Pharma, Inc. (NASDAQ:ATRS) CEO Sells $159,476.50 in Stock  2021/02/12 11:14:40 Watchlist News
Antares Pharma, Inc. (NASDAQ:ATRS) CEO Robert F. Apple sold 33,574 shares of Antares Pharma stock in a transaction that occurred on Monday, February 8th. The shares were sold at an average price of $4.75, for a total transaction of $159,476.50. Following the completion of the sale, the chief executive officer now owns 2,328,729 shares of […]
   Atrium prices debut green bond  2021/02/01 07:51:00 Property Week
Atrium European Real Estate, the central European retail investment group, raised four times the its €300m (£265m) target for its inaugural green bond.
   The Daily Biotech Pulse: Novartis Misses, J&J Beats In Big Pharma Earnings, Vaccine Developer CureVac Taps Equity Market  2021/01/26 13:07:39 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Jan. 25) Abbott Laboratories (NYSE: ABT ) Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN ) Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY ) Antares Pharma Inc (NASDAQ: ATRS ) Applied Molecular Transport Inc. (NASDAQ: AMTI ) argenx SE – ADR (NASDAQ: ARGX ) Aurinia Pharmaceuticals Inc (NASDAQ: AUPH ) (announced FDA approval for its oral lupus nephritis drug) Axonics Modulation Technologies Inc (NASDAQ: AXNX ) Beigene Ltd (NASDAQ: BGNE ) BioNano Genomics Inc (NASDAQ: BNGO ) (reacted to positive sell-side commentary) Cassava Sciences Inc (NASDAQ: SAVA ) ChemoCentryx Inc (NASDAQ: CCXI ) Clearpoint Neuro Inc (NASDAQ: CLPT ) DarioHealth Corp (NASDAQ: DRIO ) DermTech Inc (NASDAQ: DMTK ) Edap Tms SA (NASDAQ: EDAP ) Eli Lilly And Co (NYSE: LLY ) (reacted to positive Phase 3 data for its COVID-19 antibody treatment bamlanivimab) Ekso Bionics Holdings Inc (NASDAQ: EKSO ) ENDRA Life Sciences Inc (NASDAQ: NDRA ) Evogene Ltd (NASDAQ: EVGN ) EXACT Sciences Corporation (NASDAQ: EXAS ) GW Pharmaceuticals PLC- ADR (NASDAQ: GWPH ) Halozyme Therapeutics, Inc.
   Needleless Syringe Market (Impact of COVID-19) Segmentation, SWOT Analysis, Opportunities and Forecast To 2026 | Portal Instruments, 3M,BD, B. Braun Medical, Medline Industries, Inc., Antares Pharma, Inc., Injex Pharma AG,PharmaJet  2021/01/21 09:14:46 OpenPR
The report referring to the Needleless Syringe market is one of the most widespread and with key impactful additions designed for the buyers. Market Growth Insight has delivered detailed analysis and research on the major aspects of the market including
   Global Drug Delivery Market Promising Growth Opportunities Over 2020 To 2027||Top Leaders-Johnson & Johnson Services, Inc., Novartis AG, F. Hoffmann-la Roche Ltd, Bayer AG, Pfizer Inc., 3M, Antares Pharma, GlaxoSmithKline Plc  2021/01/04 05:35:32 OpenPR
Databridgemarketresearch.com Present “Global Drug Delivery Market – Industry Trends and Forecast to 2027” new report to its research database. This research report includes the profiles of the key companies along with their SWOT analysis and market strategies. This research report
   Atrium prices debut green bond  2021/02/01 07:51:00 Property Week
Atrium European Real Estate, the central European retail investment group, raised four times the its €300m (£265m) target for its inaugural green bond.
   The Daily Biotech Pulse: Novartis Misses, J&J Beats In Big Pharma Earnings, Vaccine Developer CureVac Taps Equity Market  2021/01/26 13:07:39 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Jan. 25) Abbott Laboratories (NYSE: ABT ) Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN ) Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY ) Antares Pharma Inc (NASDAQ: ATRS ) Applied Molecular Transport Inc. (NASDAQ: AMTI ) argenx SE – ADR (NASDAQ: ARGX ) Aurinia Pharmaceuticals Inc (NASDAQ: AUPH ) (announced FDA approval for its oral lupus nephritis drug) Axonics Modulation Technologies Inc (NASDAQ: AXNX ) Beigene Ltd (NASDAQ: BGNE ) BioNano Genomics Inc (NASDAQ: BNGO ) (reacted to positive sell-side commentary) Cassava Sciences Inc (NASDAQ: SAVA ) ChemoCentryx Inc (NASDAQ: CCXI ) Clearpoint Neuro Inc (NASDAQ: CLPT ) DarioHealth Corp (NASDAQ: DRIO ) DermTech Inc (NASDAQ: DMTK ) Edap Tms SA (NASDAQ: EDAP ) Eli Lilly And Co (NYSE: LLY ) (reacted to positive Phase 3 data for its COVID-19 antibody treatment bamlanivimab) Ekso Bionics Holdings Inc (NASDAQ: EKSO ) ENDRA Life Sciences Inc (NASDAQ: NDRA ) Evogene Ltd (NASDAQ: EVGN ) EXACT Sciences Corporation (NASDAQ: EXAS ) GW Pharmaceuticals PLC- ADR (NASDAQ: GWPH ) Halozyme Therapeutics, Inc.
   Needleless Syringe Market (Impact of COVID-19) Segmentation, SWOT Analysis, Opportunities and Forecast To 2026 | Portal Instruments, 3M,BD, B. Braun Medical, Medline Industries, Inc., Antares Pharma, Inc., Injex Pharma AG,PharmaJet  2021/01/21 09:14:46 OpenPR
The report referring to the Needleless Syringe market is one of the most widespread and with key impactful additions designed for the buyers. Market Growth Insight has delivered detailed analysis and research on the major aspects of the market including
   Global Drug Delivery Market Promising Growth Opportunities Over 2020 To 2027||Top Leaders-Johnson & Johnson Services, Inc., Novartis AG, F. Hoffmann-la Roche Ltd, Bayer AG, Pfizer Inc., 3M, Antares Pharma, GlaxoSmithKline Plc  2021/01/04 05:35:32 OpenPR
Databridgemarketresearch.com Present “Global Drug Delivery Market – Industry Trends and Forecast to 2027” new report to its research database. This research report includes the profiles of the key companies along with their SWOT analysis and market strategies. This research report
   Covid19 Impact on Needle-Free Diabetes Care Market 2020 With Top Leaders -Antares Pharma, Bioject Medical Technologies, Endo International, European Pharma Group, PharmaJet, Medical International Technology, Etc..  2020/12/08 17:01:22 OpenPR
Needle-Free Diabetes Care Market Overview: One of the root causes of diabetes is a group of metabolic disorders that gets triggered by insulin deficiency. The most feasible way to deliver insulin is by using injections. However, many would prefer staying away
   Atrium prices debut green bond  2021/02/01 07:51:00 Property Week
Atrium European Real Estate, the central European retail investment group, raised four times the its €300m (£265m) target for its inaugural green bond.
   The Daily Biotech Pulse: Novartis Misses, J&J Beats In Big Pharma Earnings, Vaccine Developer CureVac Taps Equity Market  2021/01/26 13:07:39 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Jan. 25) Abbott Laboratories (NYSE: ABT ) Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN ) Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY ) Antares Pharma Inc (NASDAQ: ATRS ) Applied Molecular Transport Inc. (NASDAQ: AMTI ) argenx SE – ADR (NASDAQ: ARGX ) Aurinia Pharmaceuticals Inc (NASDAQ: AUPH ) (announced FDA approval for its oral lupus nephritis drug) Axonics Modulation Technologies Inc (NASDAQ: AXNX ) Beigene Ltd (NASDAQ: BGNE ) BioNano Genomics Inc (NASDAQ: BNGO ) (reacted to positive sell-side commentary) Cassava Sciences Inc (NASDAQ: SAVA ) ChemoCentryx Inc (NASDAQ: CCXI ) Clearpoint Neuro Inc (NASDAQ: CLPT ) DarioHealth Corp (NASDAQ: DRIO ) DermTech Inc (NASDAQ: DMTK ) Edap Tms SA (NASDAQ: EDAP ) Eli Lilly And Co (NYSE: LLY ) (reacted to positive Phase 3 data for its COVID-19 antibody treatment bamlanivimab) Ekso Bionics Holdings Inc (NASDAQ: EKSO ) ENDRA Life Sciences Inc (NASDAQ: NDRA ) Evogene Ltd (NASDAQ: EVGN ) EXACT Sciences Corporation (NASDAQ: EXAS ) GW Pharmaceuticals PLC- ADR (NASDAQ: GWPH ) Halozyme Therapeutics, Inc.
   Needleless Syringe Market (Impact of COVID-19) Segmentation, SWOT Analysis, Opportunities and Forecast To 2026 | Portal Instruments, 3M,BD, B. Braun Medical, Medline Industries, Inc., Antares Pharma, Inc., Injex Pharma AG,PharmaJet  2021/01/21 09:14:46 OpenPR
The report referring to the Needleless Syringe market is one of the most widespread and with key impactful additions designed for the buyers. Market Growth Insight has delivered detailed analysis and research on the major aspects of the market including
   Global Drug Delivery Market Promising Growth Opportunities Over 2020 To 2027||Top Leaders-Johnson & Johnson Services, Inc., Novartis AG, F. Hoffmann-la Roche Ltd, Bayer AG, Pfizer Inc., 3M, Antares Pharma, GlaxoSmithKline Plc  2021/01/04 05:35:32 OpenPR
Databridgemarketresearch.com Present “Global Drug Delivery Market – Industry Trends and Forecast to 2027” new report to its research database. This research report includes the profiles of the key companies along with their SWOT analysis and market strategies. This research report
   Covid19 Impact on Needle-Free Diabetes Care Market 2020 With Top Leaders -Antares Pharma, Bioject Medical Technologies, Endo International, European Pharma Group, PharmaJet, Medical International Technology, Etc..  2020/12/08 17:01:22 OpenPR
Needle-Free Diabetes Care Market Overview: One of the root causes of diabetes is a group of metabolic disorders that gets triggered by insulin deficiency. The most feasible way to deliver insulin is by using injections. However, many would prefer staying away

 関連キーワード  (医療機器_医療用品_ディストリビュ―タ― 米国株 アンタレス・ファ―マ ATRS Antares Pharma Inc.)

医療で使われる機器のこと。レントゲン装置やからだの断面を画像化できるMRI(磁気共鳴画像)装置など高機能機器を含め数多くの種類がある。医療現場で使われるため、正確で精密である点などが求められる。医療機器への需要は着実に高まっており、電機メーカーなどからの進出も進んでいる。

 twitter  (公式ツイッターやCEOツイッターなど)